DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparison with other vaccines

被引:193
作者
Davis, HL
McCluskie, MJ
Gerin, JL
Purcell, RH
机构
[1] UNIV OTTAWA,FAC HLTH SCI,PROGRAM PHYSIOTHERAPY,OTTAWA,ON K1H 8M5,CANADA
[2] UNIV OTTAWA,FAC MED,DEPT PHYSIOL,OTTAWA,ON K1H 8M5,CANADA
[3] GEORGETOWN UNIV,MED CTR,DIV MOL VIROL & IMMUNOL,ROCKVILLE,MD 20852
[4] NIAID,INFECT DIS LAB,NIH,BETHESDA,MD 20892
关键词
D O I
10.1073/pnas.93.14.7213
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vaccination of two chimpanzees against hepatitis B virus (HBV) by intramuscular injection of plasmid DNA encoding the major and middle HBV envelope proteins induced group-, subtype- and preS2-specific antibodies. These were initially of IgM isotype, and then they were of IgG (predominantly IgG1) isotype, The chimpanzee injected with 2 mg of DNA attained >100 milli-international units/ml of anti-HBs antibody after one injection and 14,000 milli-international units/ml after four injections. A smaller dose (400 mu g) induced lower and transient titers, but a strong anamnestic response occurred 1 year later. Comparison with responses in 23 chimpanzees receiving various antigen-based HBV vaccines suggests that the DNA approach is promising for prophylactic immunization against HBV.
引用
收藏
页码:7213 / 7218
页数:6
相关论文
共 36 条
[1]  
BUYNAK EB, 1976, P SOC EXP BIOL MED, V151, P694, DOI 10.3181/00379727-151-39288
[2]  
Coates RA, 1988, VIRAL HEPATITIS LIVE, P1038
[3]   DNA-BASED IMMUNIZATION INDUCES CONTINUOUS SECRETION OF HEPATITIS-B SURFACE-ANTIGEN AND HIGH-LEVELS OF CIRCULATING ANTIBODY [J].
DAVIS, HL ;
MICHEL, ML ;
WHALEN, RG .
HUMAN MOLECULAR GENETICS, 1993, 2 (11) :1847-1851
[4]   DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[5]   DIRECT GENE-TRANSFER IN SKELETAL-MUSCLE - PLASMID DNA-BASED IMMUNIZATION AGAINST THE HEPATITIS-B VIRUS SURFACE-ANTIGEN [J].
DAVIS, HL ;
MICHEL, ML ;
MANCINI, M ;
SCHLEEF, M ;
WHALEN, RG .
VACCINE, 1994, 12 (16) :1503-1509
[6]  
DAVIS HL, 1995, MOL CELL BIOL HUMAN, P368
[7]  
DAVIS HL, 1996, IN PRESS VACCINE, V14
[8]  
DeKruyff R H, 1993, Semin Immunol, V5, P421, DOI 10.1006/smim.1993.1048
[9]  
ELLIS RW, 1993, HEPATITIS B VACCINES
[10]  
Erwin J, 1992, CHIMPANZEE CONSERVAT, P65